Women can bear increased risk for breast cancer. Well known is the heriditary risk related to mutations in BRCA1 and BRCA2 genes. Genetic tests of breast tissue disclose high risk biomolecular profiles in these women. Treatment with pregnancy hormone, beta-hCG, could change this high risk profile and convert it to low risk. A clinical study
MedInvents offers a complete range of biopsy devices and related technology to address the needs of the medical community in providing sufficient high quality tissues for molecular biology diagnostics and cell transfer, that will guarantee the best care for chronically ill patients and improve life in general.
Our minimal invasive large core soft tissue biopsy products have the highest level of accuracy, safety, and comfort with total control. The procedure is fast and easy, and affordable for everyone.
But MedInvents is much more. In response to the needs of the medical community new products and services have been developed. Please have a look at the following pages.
In addition, MedInvents offers clinical training, tutorials, on-site help and presentations of all clinical applications in which the new technology is used.